DOSING REGIMEN COMPRISING 3-(1-OXOISOINDOLIN-2-YL)PIPERIDINE-2,6- DIONE DERIVATIVES

The present disclosure relates to dosing regimens comprising 3-(1-oxoisoindolin-2-yl)piperidine-2,6-dione compounds or pharmaceutical compositions, pharmaceutical formulations, or combinations comprising the same; and methods of using such compounds, combinations, and compositions in the treatment o...

Full description

Saved in:
Bibliographic Details
Main Authors RANDOLPH Joanne Choi, KATTENHORN Lisa Marie, STRAUB Christopher Sean, KHANSHAN Fariba, D''HENNEZEL Eva Marie Genevieve, GU Yi, KWAK Eunice Lee
Format Patent
LanguageEnglish
Spanish
Published 24.01.2023
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present disclosure relates to dosing regimens comprising 3-(1-oxoisoindolin-2-yl)piperidine-2,6-dione compounds or pharmaceutical compositions, pharmaceutical formulations, or combinations comprising the same; and methods of using such compounds, combinations, and compositions in the treatment or prevention IKAROS Family Zinc Finger 2 (IKZF2)-dependent diseases or disorders or where reduction of IKZF2 or IKZF4 protein levels can ameliorate a disease, for example, the treatment of cancers. La presente invención se refiere a regímenes de dosificación que comprenden compuestos de 3-(1-oxoisoindolin-2-il)piperidina-2,6-di ona o composiciones farmacéuticas, formulaciones farmacéuticas o combinaciones que las comprenden; y métodos de uso de tales compuestos, combinaciones y composiciones en el tratamiento o prevención de enfermedades o trastornos dependientes de la proteína de dedos de zinc 2 de la Familia IKAROS (IKZF2) o donde la reducción de los niveles de proteína IKZF2 o IKZF4 puede mejorar una enfermedad, por ejemplo, el tratamiento de cánceres.
Bibliography:Application Number: MX20220015852